British pharma giant AstraZeneca to invest $2.5 billion in new China hub

British pharma giant AstraZeneca to invest .5 billion in new China hub

Outside the Macclesfield factory of AstraZeneca.

Christopher Furlong | Getty Images News | Getty Images

British pharmaceutical giant AstraZeneca on Friday said that it will invest $2.5 billion in a research and development center in Chinese capital Beijing.

The new hub is expected to take AstraZeneca’s Beijing workforce to around 1,700 employees.

Don’t miss AstraZeneca’s CEO Pascal Soriot interview live on CNBC International at 11:30 a.m. London time / 7:30 a.m. ET.

This breaking news story is being updated.

Source

Health

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale

December 23, 2025

Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill market. Eli Lilly stock slipped about half a percent this morning, while Novo Nordisk shares surged more than 8% after becoming the first to secure FDA approval for a GLP-1 weight-loss pill. “[Novo] got approval ahead of […]

Health

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

December 22, 2025

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, Nov. 24, 2025. Tom Little | Reuters The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts […]

Health

UnitedHealth Group commits to improvements after independent audit, patient backlash

December 19, 2025

UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans | Reuters UnitedHealth Group on Friday released the first results from a sprawling independent audit of its business practices and committed to a wide range of steps to track and implement improvements in three specific areas. The health-care […]